To provide optimal clinical care for primary and secondary brain tumor patients. Our team includes Neuro-oncologists, Neurosurgeons, Radiation Oncologists, Neurologists, Oncologists, Endocrinologists, Radiologists, Ophthalmologists, Pathologists, and Otolaryngologists. The Neuro-Oncology Division also has a highly active, laboratory-based as well as clinical research enterprise.
The Neuro-Oncology Division is composed of both clinical and research arms. The clinical arm is focused on providing: (1) diagnoses, treatment, and care of patients with tumors that impact the brain, spinal cord and patients with neurocutaneous syndromes; (2) care of brain tumor survivors. The research arm aims to translate lab discoveries of researchers to treat primary brain tumors, secondary or metastatic brain tumors, cancer survivorship and cancer healthcare disparities.
Clinical interests of the division of neuro-oncology include the treatment of brain tumors (such as glioblastoma, astrocytoma, oligodendroglioma, meningioma, medulloblastoma), metastatic central nervous system tumors (brain metastases, spinal cord metastases, spinal fluid or leptomeningeal metastases), and radiation necrosis.